# Transcriptional coordination in multicellular lineage differentiation during lung organogenesis: deciphering the role of epithelial cells as a microenvironmental regulatory hub

**Authors:** Chunyan Zhang, Jin Liu, Yanxia Li, Bing Han, Min Liu, Jie Zheng, Xiaozhi Liu

PMC · DOI: 10.3389/fcell.2026.1737571 · Frontiers in Cell and Developmental Biology · 2026-02-20

## TL;DR

This review explores how epithelial cells guide lung development by controlling cell differentiation and signaling during organ formation.

## Contribution

The paper highlights the dual regulatory role of epithelial cells in lung development and their impact on cell fate and regeneration.

## Key findings

- Epithelial cells act as a central hub regulating spatial patterning and cell differentiation during lung development.
- They orchestrate developmental fates through multiple signaling cues and influence stem cell regenerative properties.
- The insights may improve strategies for lung regeneration and disease intervention.

## Abstract

Lung development is a complex and precisely regulated process of continuously branching morphogenesis, the core of which lies in the directed differentiation of diverse cell types and the dynamic intercellular interaction network. This review systematically delineates the differentiation pathways of major cellular lineages during pulmonary development, with a particular focus on the dual functions of epithelial cells as the core regulatory hub of the microenvironment. These cells not only dominate the spatial patterning of lung branching morphogenesis but also orchestrate the developmental fates of key cell types through multiple signaling cues. Furthermore, this review discusses the regenerative properties of lung-resident stem cells and the interaction patterns between various cell types and epithelial cells. These insights not only provide an important theoretical framework for elucidating the molecular regulatory network of lung development but also offer novel ideas for the optimization of strategies in lung regenerative medicine and the precision intervention for lung-related diseases.

## Full-text entities

- **Genes:** GRIA2 (glutamate ionotropic receptor AMPA type subunit 2) [NCBI Gene 2891] {aka GLUR2, GLURB, GluA2, GluR-K2, HBGR2, NEDLIB}, HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 3172] {aka FRTS4, HNF4, HNF4a7, HNF4a8, HNF4a9, HNF4alpha}, THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070] {aka CD90, CDw90}, Car4 (carbonic anhydrase 4) [NCBI Gene 12351] {aka Ca4}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, FGFR2 (fibroblast growth factor receptor 2) [NCBI Gene 2263] {aka BBDS, BEK, BFR-1, CD332, CEK3, CFD1}, CTHRC1 (collagen triple helix repeat containing 1) [NCBI Gene 115908], HHIP (hedgehog interacting protein) [NCBI Gene 64399] {aka HIP}, SPDEF (SAM pointed domain containing ETS transcription factor) [NCBI Gene 25803] {aka PDEF, bA375E1.3}, Hey1 (hairy/enhancer-of-split related with YRPW motif 1) [NCBI Gene 15213] {aka CHF2, HRT1, Herp2, Hesr1, bHLHb31, hesr-1}, RSPO2 (R-spondin 2) [NCBI Gene 340419] {aka CRISTIN2, HHRRD, TETAMS2}, ETV5 (ETS variant transcription factor 5) [NCBI Gene 2119] {aka ERM}, ACKR3 (atypical chemokine receptor 3) [NCBI Gene 57007] {aka CMKOR1, CXC-R7, CXCR-7, CXCR7, GPR159, RDC-1}, CD200R1 (CD200 receptor 1) [NCBI Gene 131450] {aka CD200R, HCRTR2, MOX2R, OX2R}, WNT2 (Wnt family member 2) [NCBI Gene 7472] {aka INT1L1, IRP}, SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}, CD34 (CD34 molecule) [NCBI Gene 947], MGP (matrix Gla protein) [NCBI Gene 4256] {aka GIG36, MGLAP, NTI}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, ANGPT1 (angiopoietin 1) [NCBI Gene 284] {aka AGP1, AGPT, AGPT-1, ANG1, HAE5}, SCUBE2 (signal peptide, CUB domain and EGF like domain containing 2) [NCBI Gene 57758] {aka CEGB1, CEGF1, CEGP1, scube/You}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, FOXJ1 (forkhead box J1) [NCBI Gene 2302] {aka CILD43, FKHL13, HFH-4, HFH4}, IL33 (interleukin 33) [NCBI Gene 90865] {aka C9orf26, DVS27, IL1F11, NF-HEV, NFEHEV}, MAP3K7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 6885] {aka CSCF, FMD2, MEKK7, TAK1, TGF1a}, BMPR1B (bone morphogenetic protein receptor type 1B) [NCBI Gene 658] {aka ALK-6, ALK6, AMD3, AMDD, BDA1D, BDA2}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, Tafazzin (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 66826] {aka 5031411C02Rik, 9130012G04Rik, G4.5, Taz}, SCGB1A1 (secretoglobin family 1A member 1) [NCBI Gene 7356] {aka CC10, CC16, CCPBP, CCSP, UGB, UP-1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, HOPX (HOP homeobox) [NCBI Gene 84525] {aka CAMEO, HOD, HOP, LAGY, NECC1, OB1}, DLL4 (delta like canonical Notch ligand 4) [NCBI Gene 54567] {aka AOS6, delta4, hdelta2}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, CD200 (CD200 molecule) [NCBI Gene 4345] {aka MOX1, MOX2, MRC, OX-2}, CA4 (carbonic anhydrase 4) [NCBI Gene 762] {aka CAIV, Car4, RP17}, TUBA1A (tubulin alpha 1a) [NCBI Gene 7846] {aka B-ALPHA-1, LIS3, TUBA3}, GRP (gastrin releasing peptide) [NCBI Gene 2922] {aka BN, GRP-10, preproGRP, proGRP}, S100A4 (S100 calcium binding protein A4) [NCBI Gene 6275] {aka 18A2, 42A, CAPL, FSP1, MTS1, P9KA}, COL15A1 (collagen type XV alpha 1 chain) [NCBI Gene 1306], LRP5 (LDL receptor related protein 5) [NCBI Gene 4041] {aka BMND1, EVR1, EVR4, HBM, LR3, LRP-5}, Kdr (kinase insert domain protein receptor) [NCBI Gene 16542] {aka 6130401C07, Flk-1, Flk1, Krd-1, Ly73, VEGFR-2}, AGER (advanced glycosylation end-product specific receptor) [NCBI Gene 177] {aka RAGE, SCARJ1, sRAGE}, SSUH2 (ssu-2 homolog) [NCBI Gene 51066] {aka C3orf32, DTDP1C, SSU-2, fls485}, AGTR2 (angiotensin II receptor type 2) [NCBI Gene 186] {aka AT2, ATGR2, MRX88}, Prox1 (prospero homeobox 1) [NCBI Gene 19130] {aka A230003G05Rik, PROX-1}, TAFAZZIN (tafazzin, phospholipid-lysophospholipid transacylase) [NCBI Gene 6901] {aka BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX}, ID2 (inhibitor of DNA binding 2) [NCBI Gene 3398] {aka GIG8, ID2A, ID2H, bHLHb26}, SFTPC (surfactant protein C) [NCBI Gene 6440] {aka BRICD6, PSP-C, SFTP2, SMDP2, SP-C}, PI16 (peptidase inhibitor 16) [NCBI Gene 221476] {aka CD364, CRISP9, MSMBBP, PSPBP}, KRT14 (keratin 14) [NCBI Gene 3861] {aka CK14, EBS1, EBS1A, EBS1B, EBS1C, EBS1D}, Il13 (interleukin 13) [NCBI Gene 16163] {aka Il-13}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, Flt4 (FMS-like tyrosine kinase 4) [NCBI Gene 14257] {aka Chy, Flt-4, VEGFR-3, VEGFR3}, VIM (vimentin) [NCBI Gene 7431], IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}
- **Diseases:** airway malformations (MESH:D000402), airway metaplasia (MESH:D008679), lung agenesis (MESH:C562992), pulmonary hemorrhage (MESH:D006470), hypoxic (MESH:D002534), alveolar proteinosis (MESH:D011649), pulmonary inflammation (MESH:D011014), chronic obstructive pulmonary disease (MESH:D029424), vascular abnormalities (MESH:D014652), lung developmental disorders (MESH:D008171), failure of (MESH:D051437), alveolar damage (MESH:D055370), emphysema (MESH:D004646), fibrosis (MESH:D005355), inflammation (MESH:D007249), alveolar injury (MESH:D014947), pulmonary fibrosis (MESH:D011658), infection (MESH:D007239), IPF (MESH:D054990), vascular remodeling (MESH:D066253), PMCs (MESH:D018301), cytotoxic (MESH:D064420), bronchopulmonary dysplasia (MESH:D001997)
- **Chemicals:** naphthalene (MESH:C031721), PGE2 (MESH:D015232), heparin (MESH:D006493), serotonin (MESH:D012701), lipid (MESH:D008055), amines (MESH:D000588), DAPT (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** AT1 — Mus musculus (Mouse), Hybridoma (CVCL_C7RB)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12963316/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12963316/full.md

## References

216 references — full list in the complete paper: https://tomesphere.com/paper/PMC12963316/full.md

---
Source: https://tomesphere.com/paper/PMC12963316